Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
Phase 1
Completed
- Conditions
- Childhood Solid TumorMalignant Solid Tumor
- Interventions
- First Posted Date
- 2012-08-22
- Last Posted Date
- 2017-06-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 21
- Registration Number
- NCT01670175
- Locations
- 🇺🇸
UCSF Benioff Children's Hospital, San Francisco, California, United States
Antioxidants for Prevention of Cataracts Follow-up Study
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Dietary Supplement: AntioxidantDietary Supplement: Placebo
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2018-10-30
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 576
- Registration Number
- NCT01664819
- Locations
- 🇮🇳
Aravind Eye Hospitals, Madurai, Tamil Nadu, India
Pilot Trial of CenteringPregnancy With Mindfulness Skills
Not Applicable
Completed
- Conditions
- Low Birth WeightPremature BirthPostpartum Depression
- Interventions
- Behavioral: CenteringPregnancyBehavioral: CenteringPregnancy with Mindfulness Skills
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 49
- Registration Number
- NCT01646463
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Hyperglycemia in Renal Transplantation
Not Applicable
Completed
- Conditions
- End Stage Renal DiseaseDiabetes
- Interventions
- Drug: Insulin, Asp(B28)-
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 60
- Registration Number
- NCT01643382
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
Prehospital Cervical Ripening Before Induction and the Maternal Experience
Not Applicable
Terminated
- Conditions
- Cervical RipeningLabor, Induced
- Interventions
- Device: Outpatient transcervical Foley balloon
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 8
- Registration Number
- NCT01641601
- Locations
- 🇺🇸
UCSF Benioff Children's Hospital, San Francisco, California, United States
Effects of Secondhand Smoke on Flight Attendant Health
Completed
- Conditions
- Cardiopulmonary Disease
- First Posted Date
- 2012-07-12
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 592
- Registration Number
- NCT01639235
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months
Not Applicable
Completed
- Conditions
- Nicotine DependenceCigarette Smoking
- Interventions
- Behavioral: Internet Smoking Cessation Web Site
- First Posted Date
- 2012-07-12
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 146
- Registration Number
- NCT01639079
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence
Not Applicable
Completed
- Conditions
- Cigarette Smoking
- Interventions
- Behavioral: Smoking abstinence
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 305
- Registration Number
- NCT01627392
- Locations
- 🇺🇸
San Francisco General Hospital, San Francisco, California, United States
San Francisco Stop Smoking App - Pilot Study
Completed
- Conditions
- Recruitment
- Interventions
- Behavioral: San Francisco Stop Smoking iPhone app
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 9935
- Registration Number
- NCT01626326
- Locations
- 🇺🇸
UCSF Psychiatry at San Francisco General Hospital, San Francisco, California, United States
Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
Phase 4
Completed
- Conditions
- BK Virus Infection
- Interventions
- Drug: Mycophenolic acid dose reduction
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2016-08-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 40
- Registration Number
- NCT01624948
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath